STAT3 upregulation occurs in CD8+ T cells during obesity-associated breast tumor progression (Zhang et al., 2020), and T cell STAT3 in turn promotes obesity, insulin resistance, and T2D (Priceman et al., 2013). The gene discussed is CD8A; the disease is type 2 diabetes mellitus.